Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
for
Prostate Cancer
Location: Hackensack NJ, Atlanta GA, Portland OR
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07543055
Phase1, Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for
Dravet Syndrome
Location: Marlboro NJ, New Haven CT, Philadelphia PA, Ottawa,
Sponsor: Epygenix
Sex: All
Age: 2+
Code: NCT04462770
Phase3, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Hackensack NJ, New York NY, New Brunswick NJ,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase1, Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Middletown NJ, Bowie MD, Norfolk VA, Cleveland OH,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
for
Allogeneic Stem Cell Transplant Recipient
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18 - 65
Code: NCT07214688
Phase2, Recruiting
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
for
Locally Advanced or Metastatic Malignant Solid Tumors
Location: Hackensack NJ, New Hyde Park NY, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07287995
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
for
Hepatocellular Carcinoma (HCC)
Location: Hackensack NJ, Nashville TN, Duarte CA, Portland OR
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07291076
Phase1, Phase2, Recruiting
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels